Total trials
51
Active
3
Phase 3
4
Total enrollment
10,330
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Peripheral Arterial Disease13
- Claudication5
- Peripheral Vascular Disease3
- Carotid Artery Disease3
- Venous Reflux3
- Peripheral Artery Disease2
- Great Saphenous Vein (GSV) With Venous Reflux Disease2
- AV Fistula2
Frequently asked questions about Medtronic Endovascular
- How many clinical trials does Medtronic Endovascular have on ClinicalTrials.gov?
- Medtronic Endovascular is listed as the lead sponsor on 51 clinical trials in ClinicalTrials.gov, 3 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Medtronic Endovascular's trials are in Phase 3?
- 4 of Medtronic Endovascular's trials are in Phase 3.
- What therapeutic areas does Medtronic Endovascular focus on?
- Medtronic Endovascular's most-studied conditions on ClinicalTrials.gov are Peripheral Arterial Disease, Claudication, Peripheral Vascular Disease, Carotid Artery Disease, Venous Reflux.